Horizon製藥公共 HZNP 深 滬
等待開盤 12-24 09:30:00 美东时间
116.30
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 116.30
- 總市值 266.33亿
- 52周最高 116.38
- 市盈率 靜 52.46
- 換手率 0.00%
- 52周最低 60.03
- 委 比 0.00%
- 總股本 2.29亿
- 歷史最高 120.535
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.965
- 每 手 1
- 風險率 0.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
Dyne Therapeutics announced the appointment of Vikram Karnani to its Board of Directors. Karnani, a seasoned executive in rare disease and biopharmaceuticals, brings extensive experience in product launches and growth. As Dyne prepares for its first potential launch in Q1 2027, Karnani's expertise aligns with the company's goal of advancing treatments for neuromuscular diseases. His appointment is expected to strengthen Dyne's commercial strategy...
12-23 12:30
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK Ab+ gMG THOUSAND OAKS, C...
12-12 07:09
AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth quarter of 2025. The d...
11-01 04:01
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Ast...
10-18 04:00
Horizon Bank Appoints Larry S. Magnesen to Serve as Independent Director
Horizon Bancorp, Inc. announces the appointment of Larry S. Magnesen as an independent director, effective October 10, 2025. With over 40 years in banking, Magnesen previously held senior roles at Fifth Third Bank and other financial institutions. He will join Horizon’s Board, contributing to key committees and leveraging his expertise to support the company's growth in the Midwest. Horizon Bancorp, with $7.7 billion in assets, provides banking a...
10-14 20:05
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenN...
10-06 21:00
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
THOUSAND OAKS, Calif., Sept. 26, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. The plan...
09-26 21:00
默沙东、辉瑞、诺和诺德，宣布减员计划
在美国特朗普政府不确定的政策影响下，今年全球制药行业在资本市场的表现低迷，关税及药品价格下调等因素导致企业成本压力上升。在近期公布的第二季度财报中，多家制药企业...
08-21 19:28
Galapagos appoints Aaron Cox as CFO
Galapagos (OTCPK:GLPGF) has announced the appointment of Aaron Cox as CFO, effective July 7, 2025. Cox succeeds Thad Huston, who will remain with the company through July 31, 2025, to ensure a smooth ...
06-23 14:35
2024 年全球大型药企薪酬最高十位 CEO
（转自：抗体圈） 尽管在 Fierce 的 2024 年制药公司首席执行官薪酬排行榜上出现了许多熟悉的名字，但多位高管的排名发生了巨大变化，而第一名被一位黑马候...
06-18 11:23
